We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

Mr Michael Rugaard Jensen

Head of Drug Discovery Pharmacology

Tumour Models London Day Two

Thursday, 7th December 2017

09.40 | Discovering Resistance Mechanisms by Insertional Mutagenesis in Mice

Michael Rugaard Jensen has a Ph.D. degree in molecular and cellular biology combined with an extensive experience in genetically engineered mice and more than 13 years of leading Oncology Drug Discovery efforts. Michael has for the past 5 year lead the Drug Discovery Pharmacology team that is using a diverse set of innovative in vivo technologies to ensure delivery of novel treatments for cancer patients.